Cargando…
Statins: benefits and risks revisited
Autores principales: | Balaz, Miroslav, Wolfrum, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660028/ https://www.ncbi.nlm.nih.gov/pubmed/31303605 http://dx.doi.org/10.18632/aging.102056 |
Ejemplares similares
-
Statins: the high risks of discontinuation and large benefits of continuation
por: Hennekens, Charle H., et al.
Publicado: (2011) -
Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
por: Hazlewood, Glen S
Publicado: (2023) -
Benefit of Early Statin Therapy in Acute Myocardial Infarction in Korea
por: Jeong, Han Saem, et al.
Publicado: (2019) -
Statin discontinuation: counterbalancing the benefits with the potential risks
por: Paraskevas, Kosmas I., et al.
Publicado: (2011) -
Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)